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Summary: To approximate the contributions of in utero, intrapartum, and post- 
natal transmission of human immunodeficiency virus type-1 (HIV-1) and to 
evaluate polymerase chain reaction (PCR) as a diagnostic tool for pediatric 
HIV infection, blood was collected at birth (cord blood), and at 3, 6-12, and 
13-24 months in 218 children born to HIV-1-seropositive mothers in Kigali, 
Rwanda. Proviral DNA was detected by a double PCR using two sets of three 
primers (gag, pol, and env). Pediatric HIV-1 infection was defined according to 
serological and clinical criteria. The probability of having a positive PCR at a 
given time was calculated by a nonparametric method. Among children with 
unequivocal evidence of infection (n = 471, it was 30.5% on cord blood and 
80.6% at 3 months. Thus, in children born to HIV-1-infected mothers, the 
estimated rate of transmission in the late postnatal period is 4.9%, and the rate 
of transmission in the intrapartum plus postnatal periods is 17.6%. Among 117 
HIV-1-uninfected children born to HIV-1-infected mothers, six (5%) had a 
false-positive PCR on cord blood. These results should be taken into account 
in designing intervention trials aimed at reducing mother-to-child transmission 
of HIV-1. Key Words: Mother-to-child transmission-Timing-Breast-feed- 
ing-Africa-Polymerase chain reaction. 
' 
Transmission of the human immunodeficiency vi- 
rus type l (HIV-l) from an infected mother to her 
child occurs in grossly 12 to 35% (1). Mother-to- 
child transmission of HIV can take place either in 
utero, during labor and delivery, or postnatally by 
breast-feeding (2-4). An estimation of the relative 
contribution of these three modes of transmission 
has never been reported. However, this is an im- 
portant issue because'the recognition of the mech- 
anisms of transmission is precisely what should pre- 
cede the implementation of rational interventions 
aimed at reducing the risk of fetuslinfant contami- 
nation. We describe hereafter an attempt to assess 
the timing of mother-to-child transmission of HIV- 1 
by a systematic follow-up of a cohort of 218 chil- 
dren born to HIV-l-infected mothers using the 
polymerase chain reaction (PCR) in Kigali, 
Rwanda. 
SUBJECTS AND METHODS 
Subjects Selection and Follow-up Address correspondence and reprint requests to Dr. P. Van de 
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A prospective cohort study of the perinatal transmission of 
HIV-1 has been ongoing in Kigali, the capital city of Rwanda, 
since November 1988. All women delivering at the maternity 
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ward of the Centre Hospitalier de Kigali (CHK) were informed 
by social workers of the objectives, constraints, and advantages 
of the study. Verbal consent was obtained from each mother 
participating in the study. Two hundred eighteen children born to 
HIV-1-seropositive mothers and 218 children bom to seronega- 
tive mothers were enrolled. Details about enrollment procedures 
are given elsewhere (5). After delivery, enrolled families were 
visited every 2 weeks by social workers who collected informa- 
tion on the health status of the children by means of standardized 
questionnaires. The children and their mothers were systemati- 
cally examined by a physician every 3 months. At that time, 
blood was drawn from both mothers and children for laboratory 
evaluation. The children born to HIV-1-seropositive mothers 
were breast-fed for a median of 579 days (range, 61,302 days) 
and a mean of 560 days (standard deviation, 332 days). 
Definition of Pediatric HN-1 Infection 
Criteria used to define children bom to seropositive mothers 
as infected with HIV-1, uninfected, or with an indeterminate 
status are drawn from a Working Group consensus on Mother- 
to-Child Transmission of HIV (6) and have already been used in 
this cohort (7). The use of this classification (Ghent, 1992) is 
restricted to children who had reached or could have reached the 
cut-off age of 15 months at the time of analysis. It takes into 
account the HIV-1 antibody serostatus at 15 months of age and, 
when the child died or was lost to follow-up before 15 months of 
age, the presence or absence of signs and symptoms. A child was 
considered HIV infected if (a) he or she developed the acquired 
immunodeficiency syndrome (AIDS) according to the World 
Health Organization clinical case definition (8) or its revised ver- 
sion (9) regardless of his or her age or (b) died of HIV-related 
death (6) or (c) was HIV antibody positive at 15 months. A child 
was considered HIV uninfected if (a) he or she was HIV anti- 
body negative at 15 months or (b) had been lost to follow-up or 
died of HIV-unrelated cause and was HIV antibody negative at 
9 months or older. All other children were considered as having 
an indeterminate status with regard to HIV infection, especially 
those who died during the neonatal period. 
According to the proposed classification, 46 of the 218 children 
born to HIV-1-infected mothers were considered HIV-1 infected 
at 15 months of age. In addition, one AIDS-free child developed 
HIV antibodies after 15 months and after a transient period of 
seroreversion and was considered HIV-1 infected at 24 months 
(10). Thus the sample of HIV-1-infected children at 24 months 
consisted of 47 subjects (Group 1). One hundred thirty-nine chil- 
dren were considered HIV-1 uninfected at 24 months (Group 2). 
For 32 children, the HIV-1 infection status remained indetermi- 
nate (Group 3). A random sample of 103 HIV-1-uninfected chil- 
dren bom to HIV-l-seronegative mothers was also selected for 
our study (Group 4). 
Serological Methods 
Every 3 months, blood was drawn from mothers and children. 
Serum samples were screened by a commercial enzyme immu- 
noaksay (EIA, Vironostika, Organon Teknika, Boxtel, The 
Netherlands). AU positive samples were further confirmed by a 
commercial Western blot technique (Du Pont de Nemours, Wil- 
mington, DE, U.S.A.) using the Centers for Disease Control 
criteria for interpretation (11). 
Polymerase Chain Reaction (PCR) 
DNA from the peripheral blood mononuclear cells (PBMCs) 
was extracted as described earlier (12). Two rounds of amplifi- 
cation were performed on PBMCs collected at birth (cord blood), 
3, 6-12, and 13-24 months of age. The double PCR procedure 
was performed by means of two sets of three primer pairs (gag 
881-882, pol 001-004, env 401-404 and gag 883-990, pol 002-003, 
env 402-403), 40 cycles in a Perkin-Elmer Cetus DNA Thermal 
Cycler and Perkin-Elmer Cetus GeneAmp kits. This technique 
has already been extensively described elsewhere (12). A PCR 
was considered positive in presence of a detectable signal for at 
least two of the three primer pairs. All lysates with a negative 
PCR result on cord blood were amplified for the conserved re- 
gion human leukocyte antigen (HLA)-DQ by means of the primer 
Gh26-Gh27 (13). The detection of amplified HLA-DQ alpha nu- 
cleic acid sequences provides a measurement of the quality and 
quantity of each extracted DNA sample. Thus samples with a 
negative PCR result for HLA-DQ alpha gene were excluded from 
the analysis. In addition to infants’ and children’s blood samples, 
a random sample of 31 HIV-1-seropositive mothers and of 13 
HIV-1-seronegative mothers was tested blindly as additional 
controls. 
Statistical Methods 
In the group of HIV-1-infected children born to HIV- 1- 
seropositive mothers (Group l), the probability of having a pos- 
itive PCR according to the age at the time of testing was calcu- 
lated and plotted on a curve following the Turnbull method (14). 
This nonparametric method is most adequate when applied to 
interval-censored data. The Mann-Whitney test was used to 
compare the median number of tests performed in each group. 
Estimations of the transmission rates are presented with their 
95% confidence inte-vals ICI). 
RESULTS 
Description of the Study Sample 
Table 1 gives a summary of the follow-up of the 
cohort of children born to HIV-1-infected mothers 
and the number of blood samples available for PCR 
testing at each time of collection. The follow-up in 
the comparative cohort of children born to HIV-1- 
uninfected mothers was grossly equivalent to the 
follow-up of the exposed cohort (data not shown). 
Overall, 613 PCR tests were performed in children, 
482 in children born to HIV-1-seropositive mothers 
and 131 in children born to HIV-1-seronegative 
mothers. 
PCR as a Diagnostic Tool 
All HIV-1-seropositive mothers tested were PCR 
positive, and all HIV- 1-seronegative mothers 
tested negative. Only two cord blood samples 
lacked HLA-DQ alpha gene detectable by PCR and 
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TABLE 1. Summary of the jìrst two-years of follow-up of the 
cohort of cliildren born to HIV-1 infected mothers 
Cumulative 
Time number of Number (%) 
after Cumulative children Number of of samples 
birth number of lost to children available 
(mo) deaths follow-up followed-up for PCR" 
O - - 218 185 (85) 
3 11 - 207 151 (73) 
12 27 12 179 135 (75) 
24 40 21 157 11 (7) 
a Polymerase chain reaction (PCR) on 13-24 months samples 
was not systematically performed but was restricted to HIV-1- 
infected chiddren with a previous negative PCR result or with a 
single positive PCR test at 12 months of age. 
were then excluded from the analysis. Table 2 
shows the proportion of children with a positive 
PCR on at least one occasion during the follow-up, 
according to their HIV-1 infection status. The me- 
dian number of blood samples available for PCR 
was not statistically different in Group 1 and Group 
2 (Mann-Whitney test, p = 0.90). All children from 
Group 1 (HIV-1 infected) had at least one positive 
PCR result. In no instance was a negative PCR re- 
sult observed after a positive result in the previous 
trimester. Eleven positive PCR results were de- 
tected in the 139 HIV-l-uninfected children born to 
infected mothers (Group 2). Six of them were ob- 
tained from 117 cord blood samples and were fol- 
lowed by repeated negative results in the follow-up, 
suggesting a contamination by mother's blood when 
collecting cord blood. Five other positive results 
were obtained in this group, three at 3 months and 
two at 91 months. During the follow-up, these posi- 
tive PCR results were preceded and followed by 
negative results. This suggests a laboratory or a la- 
beling error. Clearing of infection is another plausi- 
ble explanation. By definition, most of the children 
who were lost to follow-up were classified in Group 
3 (undeterminate HIV-1 status). Children from this 
group had a lower number of blood samples avail- 
able for testing than children from Groups 1 and 2. 
Six of the 32 children from this group had at least 
one positive PCR result. In 103 HIV-1-uninfected 
children born to HIV- 1-seronegative mothers 
(Group 4), only one child had a positive PCR result. 
This child was free of any HIV-associated sign or 
symptom, and his mother remained HIV seronega- 
tive during the entire follow-up, but a positive PCR 
result was obtained on two occasions, on cord 
blood and at 24 months of age. 
The specificity of our PCR technique can be cal- 
culated as follows. We have to exclude from this 
calculation results obtained from cord blood sam- 
ples of children from Group 2 because maternal 
blood contamination was suggested in six of 117 
cord blood samples (5%; CI, 1-9%). Overall, 342 
PCR test results were obtained in HIV-1-uninfected 
children, 211 (328 - 117) in children from Group 2 
and 131 in children from Group 4. Because seven 
positive results were observed of these 342 tests 
(five in Group 2 and two in Group 4), an estimate of 
the specificity of our PCR technique applied to the 
diagnosis of perinatal HIV-1 infection is 98.0% (CI, 
96.5-99.5%). 
Assessment of the Timing of Transmission 
In the 47 HIV-1-infected children born to HIV- 
Linfected mothers, 42 had a blood sample tested by 
TABLE 2. Proportion of children with a positive polymerase chain reaction on at 
least one occasion 
Median number Number of 
Total number of blood children with 
of samples samples per at least one 
available child available positive PCR, 
HIV-1 infection statusa for PCR for PCR (range) n (% = n/N) 
Group 1 (n = 47) 
Mother HIV+, child HIV+ 112 3 (1-5)b 47 (100%) 
Group 2 (n = 139) 
Grow 3 (n = 32) 
Mother H I V ,  child HIY- 328 3 (I-4)b 11 (8%) 
Mdther HIV+,' child HIY? 42 2 (1-3) 6 (19%) 
Group 4 (n = 103) 
Mother HIV-, child HIV- 131  1(1-4) 1(1%) 
n, number of children. 
See Method section for definitions. 
Mann-Whitney U test (Group 1 versus Group 2), p = 0.90. 
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PCR on cord blood, 35 on blood collected at 3 
months, 27 at 6-12 months, and eight at 13-24 
months. Figure 1 shows the probability in these 
children of having a positive PCR according to age 
at the time of testing. In this group, 30.5% of chil- 
dren (CI, 15.4-51.4%) had a positive PCR on cord 
blood and 80.6% (CI, 54.4-93.6%) on the blood 
sample collected at 3 months of age. At 24 months, 
all HIV-1-infected children had had at least one 
positive PCR result. 
This allows approximation of the timing of trans- 
mission. The median estimate of the mother-to- 
child transmission rate at 24 months in this cohort is 
Two extreme estimates of the in utero, intrapartum, 
and postnatal transmission rates can be calculated 
from these data. If one considers that all HIV-1- 
infected children with a negative PCR on cord blood 
(i.e., 33, or 70% of the 47 HIV-1-infected children) 
acquired the infection intrapartum or in the postna- 
tal period, the in utero transmission rate is 0.253 X 
0.305 (see Fig. 1) X 100% = 7.7%, and intrapartum 
plus postnatal transmission rate is 0.253 x (1 - 
7 
(47 X 100)/(47 4- 139) = 25.3% (CI, 19.0-31.6%). 
1 
0.6 
U 
2 
ö 
2 0.6 
5. 
G 0.4 
s 
o e 
0.2 
0.305) x 100% = 17.6%. On the other hand, if one 
considers that the sensitivity of PCR is optimal only 
at 3 months of age and that only children with a 
positive PCR obtained after 3 months of age were 
indeed infected in the postnatal period, in utero plus 
intrapartum transmission rate is 0.253 X 0.806 (see 
Fig. 1) x 100% = 20.4%, and late postnatal trans- 
mission rate is 0.253 X (1 - 0.806) X 100% = 4.9%. 
DISCUSSION 
Several mechanisms of mother-to-child transmis- 
sion of HIV-1 have been suggested and probably 
coexist (2). In utero transmission as early as in the 
first or second trimester of gestation has been sug- 
gested by viral isolation from fetal tissues (15) and 
by identification of the CD4 molecules on the cells 
of the stroma and of the placental villi (16). Re- 
cently, nucleic acid sequences specific for HIV-1 
have been detected in fetal DNA obtained in the 
third trimester of pregnancy (17). Intrapartum 
transmission of HIV-1 has been suggested by a ret- 
rospective study of twin pairs born to HIV-1- 
O 
O 60 120 160 240 300 360 
Time (days) 
FIG. 1. Turnbull probability curve (with 95% confidence intervals) of having a positive polymerase chain reaction (PCR) ac- 
cording to age at the time of testing in 47 HIV-i-infected children born to HIV-i-infected mothers in Kigali (Rwanda), 1988-1991. 
Dotted lines represent 95% confidence intervals. 
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infected mothers (18). In this international study of 
66 twin pairs, the first-born twin had a significantly 
higher likelihood of becoming infected than the sec- 
ond-born twin. It is possible that, during delivery, 
the first-born twin is exposed to a larger amount of 
contaminated cervico-vaginal secretion than is the 
second one. Finally, postnatal transmission of 
HIV-1 has been demonstrated in mothers serocon- 
verting during the lactation period (12). In addition, 
David Dunn and colleagues performed a meta- 
analysis olf existing data on mother-to-child trans- 
mivsion rates estimated from cohort studies and 
evaluated the risk of transmission in the postpartum 
period from mothers already infected before deliv- 
ery at 14% (CI, 7-22%) (4). 
The diagnosis of HIV-1 infection in infants and 
children by means of such a sensitive technique as 
PCR applied on serial blood samples systematically 
collected at various ages in a single cohort provided 
a unique opportunity to determine the timing of 
transmission of HIV-1 from mother to child. Our 
data provide evidence that our double PCR tech- 
nique is extremely sensitive. When applied blindly, 
it discriminated between HIV infected and unin- 
fected mothers with a 100% concordance with an- 
tibody detection. Our PCR technique was also 
100% sensitive to diagnose HIV infection in our in- 
fected children. The specificity was 98.0% (CI, 
96.5-99.5%). Our study showed also that cord 
blood is probably not suitable for early diagnosis of 
HIV-1 infection in newborns because a probable 
contamination of the newborn blood sample by ma- 
ternal blood and the consequent false-positive PCR 
result was observed in six of 117 cord blood sam- 
ples from newborns further shown to be uninfected. 
In contrast to other recent studies, venous blood 
samples collected in the first days of life were not 
available in our study. Testing of these samples by 
PCR could have allowed a better description of the 
different transmission groups. It can indeed reason- 
ably be expected that a limited number of children 
with a positive PCR on cord blood had in fact been 
infected peripartum or early in life but had a posi- 
tive test on cord blood due to a contamination by 
maternal blood. 
Our methodology of evaluating the timing of 
transmission suffered a major constraint. It has 
been already demonstrated that PCR or viral isola- 
tion performed before the first month of life is pos- 
itive in only one third to one half of the children 
further shown to be infected (19-22). Various ex- 
planations have been proposed for this phenome- 
non. It is possible that fetuses infected in utero ex- 
press only minute viral replication at birth. The 
number of viral copies could then fall beyond the 
detectable level of standard PCR and viral isolation. 
Alternatively, this low rate of positivity of PCR and 
virus isolation at birth could simply reflect trans- 
mission of HIV-1 during labor or delivery or both. 
These uncertainties as to the interpretation of PCR 
results at birth and in the first month of life have 
major consequences for the analysis of our data. 
Our method of estimation of the relative impor- 
tance of each mechanism of transmission seems in 
close agreement with the definition endorsed by the 
Pediatric Virology Committee of the AIDS Clinical 
Trial Group (23). If we consider that all infected 
children who had a negative PCR at birth were in- 
deed infected either during delivery or postnatally 
via breast-feeding, the estimate of in utero transmis- 
sion rate would be 7.7%, and the maximum com- 
bined intrapartum and postnatal transmission rate, 
17.6%. This rate of in utero transmission is proba- 
bly overestimated. Indeed, it can be anticipated that 
in a subset of infected children with a positive PCR 
on cord blood, a contamination of cord blood sam- 
ple by maternal blood has occurred. If only children 
with a positive PCR obtained after 3 months of age 
were indeed infected in the postnatal period, the 
maximum estimate of the combined in utero and 
intrapartum transmission rate would be 20.4% and 
the minimal estimate of the postnatal transmission 
rate, 4.9%. It should be kept in mind that early post- 
natal transmission is also likely to lead to a positive 
PCR at 3 months of age. Thus this figure of 4.9% of 
postnatal transmission really represents late post- 
natal transmission. It is worth noting that our esti- 
mation of minimal and maximal postnatal transmis- 
sion rate (4.9 to 17.6%) fits in the range of estima- 
tions obtained by meta-analysis (7 to 22%) (4). 
In cohort studies performed in populations of in- 
fants in whom breast-feeding is uncommon, such as 
in most industrialized countries, at least 95% of the 
HIV-1-infected children have a positive PCR by 3 
months of age (22, and C. Peckham, personal com- 
munication). This contrasts sharply with the 80.6% 
(CI, 54.4-93.6%) positivity rate of PCR at 3 months 
observed in our cohort of breast-fed children. This 
observation supports the hypothesis that postnatal 
transmission of HIV-1 by breast-feeding is at least 
partly responsible for the excess of mother-to-child 
transmission rate observed in populations in which 
breast-feeding is the rule as compared with indus- 
trialized countries in which breast-feeding is dis- 
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couraged in HIV- 1-infected mothers. Nevertheless, 
in the developing world as well as in pockets of 
poverty in industrialized countries, the potential 
benefits of breast-feeding still outweigh the risk of 
HIV transmission, and breast-feeding should con- 
tinue to be recommended and promoted (24,25). In 
this context, however, known HIV- 1-infected 
mothers who can afford and apply safely artificial 
feeding may be counselled individually against 
breast-feeding. 
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